gastric cancer
Showing 26 - 50 of >10,000
The Gastric Cancer Foundation: A Gastric Cancer Registry
Recruiting
- Gastric Cancer
-
Stanford, CaliforniaStanford University, School of Medicine
Oct 24, 2022
Gastric Cancer Trial (Laparoscopic and Endoscopic Collaborative Surgery (LECS))
Not yet recruiting
- Gastric Cancer
- Laparoscopic and Endoscopic Collaborative Surgery (LECS)
- (no location specified)
Oct 26, 2023
Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)
Recruiting
- Gastric Cancer
- Serplulimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 27, 2023
Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)
Recruiting
- Gastric Cancer Stage IIIB-IIIC
- Pembrolizumab + SOX
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 7, 2023
Gastric Cancer Trial in Shanghai (NK510, Tislelizumab,atezolizumab or Trastuzumab)
Enrolling by invitation
- Gastric Cancer
- NK510
- Tislelizumab,atezolizumab or Trastuzumab
-
Shanghai, ChinaShanghai Tenth People's Hospital
Oct 22, 2023
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin
Recruiting
- Gastric Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Oct 22, 2023
Gastric Cancer Specialist Training Program in Laparoscopic
Completed
- Gastric Cancer
- gastric cancer specialist training program
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Oct 15, 2022
Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- TRK-950
- +2 more
-
Chuo Ku, JapanOsaka International Cancer Institute
Sep 14, 2023
Genomic and Dietary Aspects in Gastric Cancer Risk
Not yet recruiting
- Gastric Cancer
-
Roma, Italia, ItalyDipartimento Universitario di Scienze della Vita e Sanità Pubbli
Jun 28, 2023
Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)
Recruiting
- Gastric Cancer
- Taurine
- +4 more
-
Xi'an, Shaanxi, ChinaTang-Du Hospital
Nov 2, 2023
Gastric Cancer Metastatic to Liver Trial in Shanghai (Cryoablation, Tislelizumab, Lenvatinib)
Not yet recruiting
- Gastric Cancer Metastatic to Liver
- Cryoablation
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 6, 2023
System in Early Detection of Gastric Cancer in France. Cancer in
Recruiting
- Gastric Cancer
- Evaluation of the proportion of gastric neoplastic lesions detected by a computer-aided diagnosis system (CADx) compared with experienced endoscopists.
-
Lyon, FranceHôpital Edouard Herriot
Jun 23, 2023
Individuals With Gastric Cancer Participating in Clinical Trials
Not yet recruiting
- Gastric Cancer
- (no location specified)
Jan 16, 2023
Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,
Recruiting
- Epstein-Barr Virus Positive
- +10 more
- Capecitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Dec 10, 2022
Role of 18F-FDG PET/CT in Gastric Cancer
Not yet recruiting
- Gastric Cancer
- pet -ct
- (no location specified)
Jan 8, 2023
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)
Not yet recruiting
- Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
- XELOX combined with Fruquintinib and Sintilimab
- (no location specified)
Oct 17, 2023
LCI in Chronic Atrophic Gastritis and Early Gastric Cancer
Recruiting
- CAG - Chronic Atrophic Gastritis
- EGC - Early Gastric Cancer
- Compare color information and mucosal microvascular density
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hosptial
Nov 21, 2023
Gastric and Pancreatic Cancers in Latin America
Not yet recruiting
- Gastric Cancer
- +2 more
- Observational study
- (no location specified)
Jun 20, 2023
Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2023
A Web-based Calculator Predicts Heterogeneous Frailty
Completed
- Gastric Cancer
-
Nanjing, Jiangsu, China
- +1 more
Aug 1, 2023
Gastric Cancer Trial (Disitamab Vedotin Combined With Sintilimab)
Not yet recruiting
- Gastric Cancer
- Disitamab Vedotin Combined With Sintilimab
- (no location specified)
Jan 31, 2023
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023